Uncategorized

As many as 15.44 lakh shares of Anupam Rasayan, or 1.41% of its equity, worth ₹180 crore changed hands at ₹1,170 per share via block deals.

JPMorgan’s Rajiv Batra expects a subdued phase for emerging markets until late October, followed by an upsurge in Indian equities toward the Nifty’s 27,000 base case from mid-November to end-January. He sees the bear case of 20,500 as less likely…

Mohit Mangal, Vice President, Centrum Broking, expects FY27 to be a year of consolidation for NSE, with mid-teens growth likely from FY28 onwards.

Tariffs may never get activated or get waived, widening of Russian crude discounts, cracks may strengthen enough to offset costs, and government intervention potentially altering reported earnings are some downside risks to the ICICI Securities’ thesis.

SoftBank Group launched $10 billion and 1 billion euro notes to fund its OpenAI investment, replacing a bridge loan. Citigroup and JPMorgan are lead bookrunners.

LEAP India shares listed on the stock exchanges last month at a premium of over 4%. However, the stock is now 11.4% below its issue price of ₹159 and 15% below its listing price of ₹165.9 apiece.

Pine Labs had more than 1 million merchants, a gross transaction value (GTV) of ₹17.2 lakh crore and 7.4 billion transactions in FY26, according to Motilal Oswal. The company is also expanding across merchant segments, supported by acquisitions and the…

Shares of Concord Biotech have more than doubled in value from their issue price since making their stock market debut in August 2023.

Mixo Das, Asia Equity & Quant Strategist, JPMorgan, expects equity markets in Asia, including India, to remain volatile over the next four to six weeks amid geopolitical risks, oil price uncertainty and global rate moves. The brokerage continues to prefer…

Another losing week has dragged certain individual stocks to levels where they might find some support.